Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GluN2A-containing NMDA receptors are a subtype of N-methyl-D-aspartate (NMDA) receptors, which are ligand-gated ion channels critical for excitatory neurotransmission in the central nervous system (CNS). These receptors play essential roles in synaptic plasticity, learning, and memory. They are heterotetrameric complexes composed of two GluN1 subunits and two GluN2A subunits, conferring unique structural and functional properties. Predominantly found at postsynaptic densities in the hippocampus and neocortex, they mediate calcium influx upon activation and are critical for long-term potentiation (LTP) and overall neuronal communication efficiency. Alterations affecting these receptors have been implicated in various neurological disorders including epilepsy, intellectual disability, schizophrenia, and neurodegenerative diseases.
Modulation of calcium influx through the NMDA receptor channel
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GluN2A-containing NMDA Receptor (None).